127 related articles for article (PubMed ID: 22283108)
1. Daily prostate volume and position monitoring using implanted gold markers and on-board imaging during radiotherapy.
Kasaová L; Sirák I; Jansa J; Paluska P; Petera J
Acta Medica (Hradec Kralove); 2011; 54(4):149-52. PubMed ID: 22283108
[TBL] [Abstract][Full Text] [Related]
2. Kilovoltage intrafraction monitoring during normofractionated prostate cancer radiotherapy.
Chasseray M; Dissaux G; Lucia F; Boussion N; Goasduff G; Pradier O; Bourbonne V; Schick U
Cancer Radiother; 2020 Apr; 24(2):99-105. PubMed ID: 32201058
[TBL] [Abstract][Full Text] [Related]
3. Does hormone therapy modify the position of the gold markers in the prostate during irradiation? A daily evaluation with kV-images.
Udrescu C; De Bari B; Rouvière O; Ruffion A; Michel-Amadry G; Jalade P; Devonec M; Colombel M; Chapet O
Cancer Radiother; 2013 Jun; 17(3):215-20. PubMed ID: 23726364
[TBL] [Abstract][Full Text] [Related]
4. Day-to-day reproducibility of prostate intrafraction motion assessed by multiple kV and MV imaging of implanted markers during treatment.
Mutanga TF; de Boer HC; Rajan V; Dirkx ML; Incrocci L; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):400-7. PubMed ID: 22019244
[TBL] [Abstract][Full Text] [Related]
5. Position verification for the prostate: effect on rectal wall dose.
Haverkort MA; van de Kamer JB; Pieters BR; van Tienhoven G; Assendelft E; Lensing AL; van Herk M; de Reijke TM; Stoker J; Koning CC
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):462-8. PubMed ID: 20646865
[TBL] [Abstract][Full Text] [Related]
6. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion.
Tanyi JA; He T; Summers PA; Mburu RG; Kato CM; Rhodes SM; Hung AY; Fuss M
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1579-85. PubMed ID: 20472357
[TBL] [Abstract][Full Text] [Related]
7. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
[TBL] [Abstract][Full Text] [Related]
8. Toward planning target volume margin reduction for the prostate using intrafraction motion correction with online kV imaging and automatic detection of implanted gold seeds.
Rosario T; van der Weide L; Admiraal M; Piet M; Slotman B; Cuijpers J
Pract Radiat Oncol; 2018; 8(6):422-428. PubMed ID: 29907506
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
[TBL] [Abstract][Full Text] [Related]
10. CBCT evaluation of inter- and intra-fraction motions during prostate stereotactic body radiotherapy: a technical note.
Jmour O; Benna M; Champagnol P; Ben Mrad M; Hamrouni A; Obeid L; Lahmamssi C; Bousarsar A; Vial N; Rehailia-Blanchard A; Sotton S; Lan M; Langrand-Escure J; Vallard A; Magné N
Radiat Oncol; 2020 Apr; 15(1):85. PubMed ID: 32307017
[TBL] [Abstract][Full Text] [Related]
11. Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.
Jonsson JH; Garpebring A; Karlsson MG; Nyholm T
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1612-8. PubMed ID: 21477942
[TBL] [Abstract][Full Text] [Related]
12. Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion.
Shimizu S; Osaka Y; Shinohara N; Sazawa A; Nishioka K; Suzuki R; Onimaru R; Shirato H
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e393-9. PubMed ID: 21658857
[TBL] [Abstract][Full Text] [Related]
13. Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement.
Knybel L; Cvek J; Blazek T; Binarova A; Parackova T; Resova K
Radiat Oncol; 2021 Dec; 16(1):235. PubMed ID: 34876173
[TBL] [Abstract][Full Text] [Related]
14. A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate.
Mayyas E; Kim J; Kumar S; Liu C; Wen N; Movsas B; Elshaikh MA; Chetty IJ
Med Phys; 2014 Sep; 41(9):091709. PubMed ID: 25186384
[TBL] [Abstract][Full Text] [Related]
15. In vivo verification of proton beam path by using post-treatment PET/CT imaging.
Hsi WC; Indelicato DJ; Vargas C; Duvvuri S; Li Z; Palta J
Med Phys; 2009 Sep; 36(9):4136-46. PubMed ID: 19810487
[TBL] [Abstract][Full Text] [Related]
16. Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections.
Mutanga TF; de Boer HC; van der Wielen GJ; Hoogeman MS; Incrocci L; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1160-7. PubMed ID: 21035957
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation.
Cantin A; Gingras L; Lachance B; Foster W; Goudreault J; Archambault L
Med Phys; 2015 Dec; 42(12):7011-21. PubMed ID: 26632056
[TBL] [Abstract][Full Text] [Related]
18. Daily online localization using implanted fiducial markers and its impact on planning target volume for carcinoma prostate.
Khosa R; Nangia S; Chufal KS; Ghosh D; Kaul R; Sharma L
J Cancer Res Ther; 2010; 6(2):172-8. PubMed ID: 20622364
[TBL] [Abstract][Full Text] [Related]
19. Comparison of daily megavoltage electronic portal imaging or kilovoltage imaging with marker seeds to ultrasound imaging or skin marks for prostate localization and treatment positioning in patients with prostate cancer.
Serago CF; Buskirk SJ; Igel TC; Gale AA; Serago NE; Earle JD
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1585-92. PubMed ID: 16863936
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
